EpiPen Jr 0,15 mg otopina za injekciju u napunjenoj brizgalici
Name | EpiPen Jr 0,15 mg otopina za injekciju u napunjenoj brizgalici |
---|---|
Marketing Authorisation Number | HR-H-987056369 |
Active Substance | adrenalin (epinefrin) |
Composition | 1 ml sadrži 500 mikrograma adrenalina (epinefrina). Pojedinačna doza (0,3 ml) sadrži 0,15 mg (150 mikrograma) adrenalina |
Pharmaceutical Form | otopina za injekciju u napunjenoj brizgalici |
Manufacturer | Meda Pharma GmbH & Co. KG, Bad Homburg, Njemačka |
Marketing Authorisation Holder | Viatris Hrvatska d.o.o., Koranska 2, Zagreb, Hrvatska |
Marketing Authorisation Date | 16.03.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/17-02/275 |
Registration Number | 381-12-01/30-21-07 |
Prescription | Medicinal product subject to medical prescription |
Type of prescription | ponovljivi recept |
Distribution | Supply through pharmacies (community) |
Advertising to general public | not allowed |
ATC Code | C01CA24 |
Marketing status | stavljeno u promet |
Shortage status | nema nestašice |
SmPC | download |
PL | download |
Educational materials for healthcare professionals |
Lista provjere kod propisivanja, verzija 2 |
Educational materials for patients / caregivers |
Brošura za bolesnike, verzija 2 |
Packaging
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o povlačenju potencijalno zahvaćenih serija lijekova EpiPen 0,3 mg otopina za injekciju i EpiPen Junior 0,15 mg otopina za injekciju (epinefrin) zbog moguće neispravnosti autoinjektora | 14.04.2017 | Medical Intertrade d.o.o. |